Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience

This publication has 29 references indexed in Scilit:

• Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study
  BMC Cancer, 2014
• Safety and Efficacy of Video Laparoscopic Surgical Debulking of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
  JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons, 2012
• Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort
  British Journal of Cancer, 2011
• Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer
  International Journal of Gynecological Cancer, 2011
• Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients
  Journal of Surgical Oncology, 2010
• Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
  Gynecologic Oncology, 2009
• A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy
  Oncology, 2008
• The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer
  Annals of Oncology, 2008
• Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
  Annals of Surgical Oncology, 2006
• Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking
  American Journal of Obstetrics and Gynecology, 2004